MD Stem Cells Begins the Largest Stem Cell Eye Treatment Study to Date – MarketWatch (press release)
|
MD Stem Cells Begins the Largest Stem Cell Eye Treatment Study to Date
MarketWatch (press release) MD Stem Cells is Collaborator for the new Stem Cell Ophthalmology Treatment Study, abbreviated as SCOTS. Dr. Steven Levy, President of MD Stem Cells, will function as Study Director for the clinical trial expected to continue through August 2017. |
